Jose Antonio Encinar

13PUBLICATIONS
51CO-AUTHORS
Metabolic medicineMolecular targetsHost-parasite interactionsMolecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 04, 2024
PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity.

Eduardo H Gilglioni, Ao Li, Wadsen St-Pierre-Wijckmans

|Dec 23, 2022
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.

Sara Verdura, Jose Antonio Encinar, Eduard Teixidor

|Sep 09, 2022
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.

Sara Verdura, José Antonio Encinar, Salvador Fernández-Arroyo

|Jun 23, 2022
The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases.

Alberto Falco, Mikolaj Adamek, Patricia Pereiro

|Oct 23, 2021
Peimine, an Anti-Inflammatory Compound from Chinese Herbal Extracts, Modulates Muscle-Type Nicotinic Receptors.

Armando Alberola-Die, José Antonio Encinar, Raúl Cobo

|Aug 27, 2021
Metformin Is a Pyridoxal-5'-phosphate (PLP)-Competitive Inhibitor of SHMT2.

Angela Tramonti, Elisabet Cuyàs, José Antonio Encinar

Pageof 3